Compare Novartis AG (NVS) vs United Parcel Service Inc (UPS) Price & Performance

Novartis (NVS) trades at $143.28, up 1.77% today, with mixed technical signals showing neutral momentum. The company demonstrates strong fundamentals with $56.67B revenue in 2025, 22.5% net margin, and consistent earnings beats in recent quarters. Recent developments include a significant $7.8B licensing deal with China's Abogen for mRNA therapy, though offset by clinical trial setbacks in ALS drug development and ongoing investor scrutiny of M&A strategy.

Outlook remains cautiously optimistic with analyst consensus target of $146 suggesting modest upside. Key opportunities include pipeline expansion through strategic partnerships, while risks involve clinical trial failures, M&A integration challenges, and patent cliff pressures. The stock presents a balanced risk-reward profile with strong profitability offset by pipeline execution concerns.

UPS trades at $92.28, down 0.89% on the day, with a bearish technical signal despite recent earnings beats. The company maintains solid fundamentals with a P/E of 17.15 and ROE of 29.66%, though revenue has declined from $100.3B in 2022 to $88.7B in 2025. Recent developments include the launch of UPS Secure Commerce and an exclusive TikTok Shop partnership.

The outlook is mixed: analyst consensus price target of $118.67 suggests 29% upside, but technical indicators and recent downgrades highlight near-term pressure. Key risks include fuel costs, domestic volume concerns, and Amazon competition, while the 7% dividend yield provides income support.